Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ark Genomic Revolution ETF (NY: ARKG )

33.50 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EDT, Jun 5, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5
Open 33.50
Bid (Size) 33.50 (1)
Ask (Size) 34.57 (1)
Prev. Close 33.50
Today's Range 33.50 - 33.50
52wk Range 26.38 - 43.88
Shares Outstanding 639,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cathie Wood Trimmed This Big Tech Stock Holding But Bulked Up On SaaS Provider PagerDuty And Ginkgo Bioworks
 
Via Benzinga
Cathie Wood Sells More Nvidia Shares After Rally: Here's How Many Shares Ark Funds Owns Of AI Giant
One of the most notable exchange-traded fund families may have sold shares of Nvidia Corporation (NASDAQ: NVDA) early. The Ark Funds ETFs have continued selling Nvidia shares since the company reported... 
Via Benzinga

Performance

YTD
+21.33%
+21.33%
1 Month
+12.38%
+12.38%
3 Month
+11.18%
+11.18%
6 Month
+6.42%
+6.42%
1 Year
+5.71%
+5.71%

More News

Read More
Did Cathie Wood's Innovation ARKK ETF Whiff On AI? How It Compares To FAANG, Nvidia In 2023
Via Benzinga
Cathie Wood Loads Up On Biotech Stocks — Continues To Raise Stake In Coinbase Global
Via Benzinga
Cathie Wood Trims Stake In This Chinese E-Commerce Giant – Loads Up On Butterfly Network Stock
Via Benzinga
Move Over, ChatGPT: 5 Stock Ideas For Leveraging The Power Of AI In Health Care, Cybersecurity
Via Benzinga
10 Best Stocks to Buy in March 2023
Via The Motley Fool
Cathie Wood Makes Biggest Coinbase Purchase Of Year After Earnings Beat
Via Investor's Business Daily
3 Cathie Wood Stocks That Could More Than Double in 12 Months, According to Wall Street
Via The Motley Fool
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?
Via Talk Markets
Cathie Wood Trims Robinhood Stake As Stock Gains 28% In January — Also Offloads Shares In This Biotech Company
Via Benzinga
Why Teladoc Stock Popped 5% Today
Via The Motley Fool
Healthcare Sector Is Lagging As We Enter 2022 Earnings Season
Via Talk Markets
Don't Call It A Comeback: Cathie Wood Is Beating The S&P 500 In Early 2023
Via Benzinga
J.P.Morgan Healthcare Conference JPM23: Biotech Rally Favors Smaller Caps
Via Talk Markets
Cathie Wood Makes This Molecular Diagnostics Company Top Holding Of Ark Invest's Flagship Fund, Catapulting Past Zoom, Tesla
Via Benzinga
Cathie Wood Gets Elon Musk's Attention Over Gene-Editing Therapy Potential: 'Investors Chased The Dream Then. Now, They're Running Away'
Via Benzinga
War, Inflation, Fed Hawkishness, Elon Musk's Twitter Buy: How These Factors Weighed On Cathie Wood's Top Holdings In 2022
Via Benzinga
Precious Metals Outperformed Stocks And Bonds In 2022
Via Talk Markets
2 Cathie Wood Stocks to Buy and Hold Through 2023 and Beyond
Via The Motley Fool
'Study The Mindset Of Stonk Hodlers': This Fund Manager Rips Cathie Wood's Investment Strategy
Via Benzinga
Cathie Wood Adds $7M Of This Clinical-Stage Biotech, Trims Stake In CVS-Target Signify Health
Via Benzinga
Getting Ready For The Coming Stock Market Elevator Drop
Via Talk Markets
This Congressman Just Purchased 2 Stocks Which Consistently Increase Dividends
Via Benzinga
Cathie Wood Has Bet Big On These 10 Stocks; Here's How They're Performing
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.